• 1
    Waggoner SE. Cervical cancer. Lancet 2003; 361: 221725.
  • 2
    Li LD, Lu FZ, Zhang SW, Zhang SW, Mu R, Sun SD, Huangpu XM, Sun J, Zhou YS, Ouyang NH, Rao KQ, Chen YD, et al. Cancer mortality trends in the People's Republic of China: 1973–1992. Chinese J Oncol 1997; 19: 39.
  • 3
    Mun̆oz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 15.
  • 4
    Bosch FX, Lorincz A, Mun̆oz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 24465.
  • 5
    Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003: 208.
  • 6
    Castle PE, Giuliano AR. Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 2003: 2934.
  • 7
    Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001; 84: 121926.
  • 8
    Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev 2002; 11: 9304.
  • 9
    Bayo S, Bosch FX, de Sanjose S, Munoz N, Combita AL, Coursaget P, Diaz M, Dolo A, van den Brule AJ, Meijer CJ. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002; 31: 2029.
  • 10
    Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, Studentsov YY, McAdams M, Schiffman M. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004; 13: 157482.
  • 11
    Zhang ZF, Parkin DM, Yu SZ, Esteve J, Yang XZ. Risk factors for cancer of the cervix in a rural population in China. Int J Cancer 1989; 43: 7627.
  • 12
    Zhang ZF, Graham S, Yu SZ, Marshall J, Zielezny M, Chen YX, Sun M, Tang SL, Liao CS, Xu JL, Yang XZ. Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol 1995; 5: 32532.
  • 13
    Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, et al. Shanxi Province Cervical Cancer Screening Study II: self-sampling for high-risk human papillomavirus compared to direct sampling for HPV and liquid based cervical cytology. Int J Gynecol Cancer 2003; 13: 18.
  • 14
    Tisci SE, Shen YH, Fife D, Goycoolea JM, Ma CP, Qiao YL, Belinson JL. Patient acceptance of self-sampling for human papillomavirus in rural China. J Low Genit Tract Dis 2003; 7: 10716.
  • 15
    Pretorius RG, Zhang W-H, Belinson JL, Huang M-N, Wu L-y, Zhang X, Qiao Y-L. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191: 4304.
  • 16
    Rong S, Chen W, Wu L, Zhang X, Shen G, Liu Y, Zhao F, Ma J, Qiao Y. Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province. Zhonghua Yu Fang Yi Xue Za Zhi 2002; 36: 413.
  • 17
    Clavel C, Masure M, Putaud I, Thomas K, Bory JP, Gabriel R, Quereux C, Birembaut P. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 1998; 51: 73740.
  • 18
    Research Triangle Institute. SUDAAN user's manual, Release 8.0 Research Triangle Park, NC: Research Triangle Institute, 2002.
  • 19
    SAS Institute Inc., SAS/STAT user's guide. Version 8. Cary, NC: SAS Institute Inc., 1999.
  • 20
    Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87: 32433.
  • 21
    Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 46474.
  • 22
    Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91: 41220.
  • 23
    Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, Park S, Touze A, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003; 103: 41321.
  • 24
    Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen Thuy TT, Nguyen HN, Nguyen BD, Ashley R, Snijders PJ, Meijer CJ, Munoz N, et al. Human papillomavirus infection among women in south and north Vietnam. Int J Cancer 2003; 104: 21320.
  • 25
    Sukvirach S, Smith JS, Tunsakul S, Munoz N, Kesararat V, Opasatian O, Chichareon S, Kaenploy V, Ashley R, Meijer CJ, Snijders PJ, Coursaget P, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003; 187: 124656.
  • 26
    Wright TCJr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 816.
  • 27
    Denny L, Kuhn L, Pollack A, Wainwright H, Wright TCJr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89: 82633.
  • 28
    Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, Elson P, Fischer C, Lorincz A, Zahniser D, Wilbur D, Pan Q, Li L, et al. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer 1999; 9: 4117.
  • 29
    Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjanen K; DIANAIDS Collaborative Study Group. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS 2003; 14: 41725.
  • 30
    Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D. Shanxi Province Cervical Cancer Screening Study, a cross-sectional comparative trial of multiple techniques to detect cervical intraepithelial neoplasia. Gynecol Oncol 2001; 83: 43944.
  • 31
    Rietveld WJ, Boon ME, Meulman JJ. Seasonal fluctuations in the cervical smear detection rates for (pre)malignant changes and for infections. Diagn Cytopathol 1997; 17: 4525.
  • 32
    Hermida RC, Ayala DE, Lopez-Franco JJ, Arroyave RJ. Circannual variation in the incidence of uterine cervix cancer. Chronobiol Int 1993; 10: 5462.
  • 33
    Bosch FX, Castellsague X, Munoz N, de Sanjose S, Ghaffari AM, Gonzalez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88: 10607.
  • 34
    Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996; 174: 67989.
  • 35
    Thomas DB, Ray RM, Kuypers J, Kiviat N, Koetsawang A, Ashley RL, Qin Q, Koetsawang S. Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers. Am J Epidemiol 2001; 153: 7408.
  • 36
    Kjellberg L, Wang Z, Wiklund F, Edlund K, Angstrom T, Lenner P, Sjoberg I, Hallmans G, Wallin KL, Sapp M, Schiller J, Wadell G, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol 1999; 80: 3918.
  • 37
    Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, Gaitan E, Garcia M, Rawls WE. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer 1990; 65: 3806.
  • 38
    Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10: 10217.
  • 39
    Anorlu RI, Abdul-Kareem FB, Abudu OO, Oyekan TO. Cervical cytology in an urban population in Lagos, Nigeria. J Obstet Gynaecol 2003; 23: 2858.
  • 40
    Viikki M, Pukkala E, Nieminen P, Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000; 39: 715.
  • 41
    Sayed el-Ahl SA, el-Wakil HS, Kamel NM, Mahmoud MS. A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women. J Egypt Soc Parasitol 2002; 32: 16778.
  • 42
    Zhang ZF, Begg CB. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994; 23: 68290.
  • 43
    Sobel JD. Bacterial vaginosis. Annu Rev Med 2000; 51: 34956.
  • 44
    Bendesky A, Menendez D, Ostrosky-Wegman P. Is metronidazole carcinogenic? Mutat Res 2002; 511: 13344.
  • 45
    Pretorius RG. Clinical decision-making. In: DucatmanBS, WangHH, eds. The pap smear. London: Arnold, 2002.